18 results
6-K
CNTB
Connect Biopharma Holdings Ltd
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
and training
Others
6. Employee Benefit Expenses
Six Months Ended June 30,
RMB’000
Wages, salaries and bonuses
Share-based compensation expenses (Note
20-F
2021 FY
EX-4.10
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
and training suitable clinical investigators;
delays in obtaining required ethics committee or institutional review board, or IRB, approval at each … a REMS in order to approve our product candidates, which could entail requirements for a medication guide, physician training and communication plans
20-F
EX-4.11
7q3ua74 zk0c21w5
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
7hafmkglrf
31 Mar 22
Annual report (foreign)
4:33pm
424B4
47g1s1cx65hje
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
9oml07hjn1cd zmh31v1
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
f7xw6j75 vma
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
nivy su6s
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.14
e52j92uc
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
72cn 9mhh
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.5
c6cu izrdwe50n
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.13
v3hyyu dt4air2i3
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
hihqlx0s1ss
26 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
kfmov
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
jujtccq031skc0a84co
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next